Skip to main content
Skip table of contents

Grip Strength in Oncology: The New Essential Biomarker

This document explores how grip strength is valuable for assessing cancer-induced muscle mass and strength changes. These are indicators of a patient’s physical status and the effectiveness of their ongoing treatment.

Measuring grip strength is valuable for assessing cancer-related health changes reflecting overall muscle mass and strength impacted by the disease and its treatments. Muscle wasting, fatigue, and reduced physical activity lead to decreased grip strength, making it a critical indicator of a patient’s physical status and the effectiveness of ongoing treatment. For cancer treatment platforms, incorporating grip strength measurement is essential for understanding patient outcomes, and overlooking this metric may have detrimental consequences.

Click on the thumbnail to understand how grip strength can be used in clinical practice to assess cancer patient risk, progression and prognosis.

References can be found here

oncology thumbnail.png

JavaScript errors detected

Please note, these errors can depend on your browser setup.

If this problem persists, please contact our support.